News Pfizer, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:21 2024-05-07 pm EDT			After market 04:23:36 pm
27.77 ^USD	-1.38%		27.76	-0.02%

May. 06	BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline	MT
May. 06	Pfizer: Citi analyst appointed Chief Strategy Officer	CF

BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline	May. 06	MT
Pfizer: Citi analyst appointed Chief Strategy Officer	May. 06	CF
Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer	May. 06	MT
Pfizer Names Andrew Baum Chief Strategy, Innovation Officer	May. 06	DJ
BioNTech says 90% of 2024 revenues will accrue at end of year	May. 06	RE
Pfizer Announces New Chief Strategy and Innovation Officer	May. 06	BU
Pfizer Announces Executive Changes	May. 06	CI
Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR	May. 06	AQ
Northeast Pharmaceutical's Unit Gets Nod to Produce Azithromycin for Injection	May. 06	MT
GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	May. 03	AQ
NICE recommends new haemolytic anaemia treatment	May. 03	AQ
AM Best Affirms Credit Ratings of Blue Whale Re Ltd	May. 03	AQ
GSK plc : Back on track	May. 03
Wall Street: optimism ahead of NFP, rates ease	May. 02	CF
PFIZER INC : Buy rating from DZ Bank	May. 02	ZD
Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28	May. 02	MT
Leerink Adjusts Price Target on Pfizer to $29 From $27	May. 02	MT
BMO Capital Adjusts Pfizer's Price Target to $36 From $33, Keeps Outperform Rating	May. 02	MT
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Prepared Remarks	May. 02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Infographic	May. 02	PU

No results for this search

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs